![Hans Petter Tjeldflaat](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hans Petter Tjeldflaat
Keine laufenden Positionen mehr
Karriereverlauf von Hans Petter Tjeldflaat
Ehemalige bekannte Positionen von Hans Petter Tjeldflaat
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Affitech AS /Old/
![]() Affitech AS /Old/ Miscellaneous Commercial ServicesCommercial Services Affitech AS discovers and develops human therapeutic antibodies. It focuses on molecule and cell based antibody discovery. The company was founded by Martin Welschof, Ole Jorgen Marvik, and Michael Braunagel in 1997 and is headquartered in Oslo, Norway. | Finanzdirektor/CFO | 01.01.2006 | 16.06.2009 |
Christiania Bank Og Kreditkasse | Investor Relations Kontakt | - | - |
Nextera AS
![]() Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Finanzdirektor/CFO | - | - |
RespiNor AS
![]() RespiNor AS Electronic Equipment/InstrumentsElectronic Technology RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway. | Finanzdirektor/CFO | - | - |
Otivio AS
![]() Otivio AS Medical SpecialtiesHealth Technology Otivio AS manufactures non-invasive medical devices. The private company is based in Oslo, Norway. | Finanzdirektor/CFO | - | - |
THOR MEDICAL | Finanzdirektor/CFO | - | - |
Inovio AS | Finanzdirektor/CFO | - | - |
SND Invest AS | Chief Investment Officer | - | - |
NYKODE THERAPEUTICS | Finanzdirektor/CFO | 01.10.2012 | - |
Ausbildung von Hans Petter Tjeldflaat
Norwegian School of Economics & Business Administration | Graduate Degree |
University of Wisconsin | Graduate Degree |
Statistik
International
Norwegen | 10 |
Vereinigte Staaten | 2 |
2 |
Operativ
Director of Finance/CFO | 7 |
Graduate Degree | 2 |
Chief Investment Officer | 1 |
Sektoral
Health Technology | 5 |
Commercial Services | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NYKODE THERAPEUTICS | Health Technology |
Private Unternehmen | 8 |
---|---|
Affitech AS /Old/
![]() Affitech AS /Old/ Miscellaneous Commercial ServicesCommercial Services Affitech AS discovers and develops human therapeutic antibodies. It focuses on molecule and cell based antibody discovery. The company was founded by Martin Welschof, Ole Jorgen Marvik, and Michael Braunagel in 1997 and is headquartered in Oslo, Norway. | Commercial Services |
SND Invest AS | Finance |
Inovio AS | Health Technology |
Nordic Nanovector ASA
![]() Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Otivio AS
![]() Otivio AS Medical SpecialtiesHealth Technology Otivio AS manufactures non-invasive medical devices. The private company is based in Oslo, Norway. | Health Technology |
RespiNor AS
![]() RespiNor AS Electronic Equipment/InstrumentsElectronic Technology RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway. | Electronic Technology |
Nextera AS
![]() Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Commercial Services |
Christiania Bank Og Kreditkasse | Finance |
- Börse
- Insiders
- Hans Petter Tjeldflaat
- Erfahrung